SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-12-064951
Filing Date
2012-12-17
Accepted
2012-12-17 08:32:38
Documents
3
Period of Report
2012-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 NASH PESS RELEASE rrd362676.htm 8-K 12455
2 LOGO ljpcpic.jpg GRAPHIC 13881
3 NASH PRESS RELEASE rrd362676_38956.htm EX-99 7145
  Complete submission text file 0001181431-12-064951.txt   39996
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 121267362
SIC: 2836 Biological Products, (No Diagnostic Substances)